Looking at the impact of COVID-19 on the economy & the MedTech industry in China
Ipsos’ Medical Devices & Diagnostics (MD&D) team in China has created a series of reports, with aim to shed some light on the questions that have arisen regarding the impact of COVID-19 on the domestic economy, healthcare industry and specifically, the medical devices sector in China.
Read the part 3 / June 9 report:
Coronavirus: Global trends and impact on China’s healthcare industry (May 2020). Highlights include:
- Globally, the outbreak has been gradually brought under control after peaking
- Worried about a second wave of outbreak, China remains vigilant about COVID-19 control
- Impact on the value of healthcare is sustained, with increasing workload on health workers, due to infection control and testing
- Recovery of medical service in most regions in China has sped up
- Public hospital revenue in 2020 expects flat growth, while private ones to suffer loss
Hospital volumes and consumables tracking: An Ipsos study sampled from 40 hospitals in major provinces across China. Highlights include:
- Extent of the impact on hospital outpatient, inpatient and surgery volume
- Year-on-year comparison of surgery volume in main departments
- Change in volume of use of selected low- and high- value consumables
Ongoing reports will be added here, as they are released:
| Part 3 | June 9 |
| Part 2 | April 21 |
| Part 1 | March 25 |
